Fluorescein Sodium And Benoxinate Hydrochloride Solution/ Drops
NDC Package 24208-734-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Fluorescein Sodium And Benoxinate Hydrochloride solution/ dropses is fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. This formulation utilizes a solution/ drops delivery system. Marketed by Bausch & Lomb Incorporated, this product is identified by NDC 24208-734 and is authorized under FDA application NDA211039.

Identification & Billing

NDC Package Code
24208-734-05
Package Description
1 BOTTLE, GLASS in 1 CARTON / 5 mL in 1 BOTTLE, GLASS
Product Code
24208-734
11-Digit Billing Format
24208073405
RxNorm Crosswalk
  • RxCUI: 2287005 - benoxinate HCl 0.4 % / fluorescein sodium 0.3 % Ophthalmic Solution
  • RxCUI: 2287005 - benoxinate hydrochloride 4 MG/ML / fluorescein sodium 3 MG/ML Ophthalmic Solution
  • RxCUI: 2287005 - benoxinate hydrochloride 0.4 % / fluorescein sodium 0.3 % Ophthalmic Drops

Clinical Specifications

Proprietary Name
Fluorescein Sodium And Benoxinate Hydrochloride
Non-Proprietary Name
Fluorescein Sodium And Benoxinate Hydrochloride
Substance Name
Benoxinate Hydrochloride; Fluorescein Sodium
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent.

Regulatory & Marketing

Labeler Name
Bausch & Lomb Incorporated
Product Type
Human Prescription Drug
FDA Application #
NDA211039
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-20-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24208-734-05 identifies a specific commercial package of 1 bottle, glass in 1 carton / 5 ml in 1 bottle, glass of Fluorescein Sodium And Benoxinate Hydrochloride, a human prescription drug labeled by Bausch & Lomb Incorporated. This solution/ drops is formulated for ophthalmic use and contains benoxinate hydrochloride; fluorescein sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Incorporated on March 20, 2020. The current certification is valid through December 31, 2026.

How is this Bausch & Lomb Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24208073405. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24208-734-05
11-Digit CMS (5-4-2)
24208-0734-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.